TECHNETIUM-99M SESTAMIBI (99MTC MIBI) SINGLE-PHOTON EMISSION COMPUTERIZE TOMOGRAPHY IN THE DETECTION OF NASOPHARYNGEAL CARCINOMA

Authors

  • Sunanta CHIEWVIT Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Supatra SANGRUCHI Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Vutisiri VEERASARN Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Nan SUNTORNPONG Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Mongkol UIPRASERTKUL Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Ruentip TIPPAROJ Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • acharin RATANAMART Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University

Abstract

Nasopharyngeal carcinoma is a radiosensitive tumor. Recurrence after radiotherapy is acommon cause of treatment failure. Early diagnosis and accurate identification of residual/ recurrent disease are essential for proper patient management. It is radiobiologically necessary to booster the irradiation dose or using combined therapy for the persistent tumor after the initial course of radiotherapy. CT and MRI cannot be used in the evaluation of response to therapy in NPC. Positron Emission Tomography (PET) have proved to be valuable as metabolic imaging tracer, however, their restricted availability and high cost are inherent limitations to their uses. We evaluated 99mTc MIBI in identifying primary tumor, neck node metastases, distance metastasis and recurrence of the diseased after therapy in NPC patients. The sensitivity and specificity in identifying primary tumor were 100% and 33% respectively. 99mTc MIBI scintigraphy can detect neck nodes metastasis 13 of 15 cases. One case of lung metastases and two cases of liver metastases can be detected by 99mTc MIBI scintigraphy in our study. The sensitivity and specificity in identifying recurrence or residual tumor in pre and post treatment group and post-treatment group were 100%, 80% and 100%, 60% respectively.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Tumor registry Siriraj cancer center. Statistical report 1997. Faculty of Medicine, Siriraj Hospital Mahidol University: page 3

International Nasopharynx Cancer Study Group VUMCA I Trial preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy versus radiotherapy alone in Stage IV (2N2, MO) undifferentiated nasopharyngeal carcinoma a positive effect on progression free survival. Am J Radiat Oncol Biol Phys 1996;35:463-469.

Taifu L. Trend in the clinical management of NPC. IntJ Radiat Oncol Biol Phys 1992; 23:469-471.

Wither HR, Peter s LJ. Basic principles of radiotherapy: biological aspects of radiation therapy. In: Fletcher GH, ed. Textbook of radiotherapy, 3rd edn. Philadelphia: Lea and Febiger.1980:103-108.

Sham JST, Wei WI, Kwan WH, Chan CW, Kwong WK, Choy D. Nasopharyngeal carcinoma: pattern of tumor regression after radiotherapy. Cancer 1990;65:216- 220.

Rege S, Maas A, Chaiken L. et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73: 3047-3058.

Lindholm P, Leskinen-Kallio, Grenman R. et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and (''C) methionine. Int J Radiat Oncol Phys 1995; 32:787-794.

Abdel-Dayem H, Scott AM. Macapinlac HA, El- Gazzar AH, Larson SM. Role of Tl-201 chloride and Tc-99m-sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear medicine annual. New York: raven press; 1994:181-234.

Cumali Aktolun, Hikmet Bayhan, and Metin Kir. Clinical Experience with Tc- 99m MIBI imaging in patients with malignant tumors preliminary results and comparison with T] 201. Clin Nucl Med 1992;17:171-176.

Lale Kostakoglu, Ugur Uysal, Enis Ozyar et al. A comparative study of technetium- 99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. EurJ Nucl Med 1997;24:621-628.

Lale Kostakoglu, Ugar Uysal, Enis Ozyar et al. Monitoring response to therapy with Thallium-201 and Technetium-99msestamibi SPECT in nasopharynxgeal carcinoma. J Nucl Med 1997; 38: 1009-1014.

Downloads

Published

2023-04-12

How to Cite

1.
CHIEWVIT S, SANGRUCHI S, VEERASARN V, SUNTORNPONG N, UIPRASERTKUL M, TIPPAROJ R, et al. TECHNETIUM-99M SESTAMIBI (99MTC MIBI) SINGLE-PHOTON EMISSION COMPUTERIZE TOMOGRAPHY IN THE DETECTION OF NASOPHARYNGEAL CARCINOMA. ASEAN J Radiol [Internet]. 2023 Apr. 12 [cited 2024 Dec. 4];6(2):91-100. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/523

Issue

Section

Original Article

Most read articles by the same author(s)